Stanford University School of Medicine

Redwood City, California 94063

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Primary Biliary Cholangitis Clinical Trial
ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Redwood City, CA
Click here to add this to my saved trials